Cargando…

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application

Through epithelial-mesenchymal transition (EMT), cancer cells acquire enhanced ability of migration and invasion, stem cell like characteristics and therapeutic resistance. Notch signaling regulates cell-cell connection, cell polarity and motility during organ development. Recent studies demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Xun, Wu, Hua, Han, Na, Xu, Hanxiao, Chu, Qian, Yu, Shiying, Chen, Yuan, Wu, Kongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267749/ https://www.ncbi.nlm.nih.gov/pubmed/25477004 http://dx.doi.org/10.1186/s13045-014-0087-z

Ejemplares similares

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis
por: Yuan, Xun, et al.
Publicado: (2015)

Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis
por: Yuan, Xun, et al.
Publicado: (2015)

DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling
por: Han, Na, et al.
Publicado: (2015)

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
por: Xu, Hanxiao, et al.
Publicado: (2016)

Prognostic significance of KRT19 in Lung Squamous Cancer
por: Yuan, Xun, et al.
Publicado: (2021)

Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer
por: Sun, Wei, et al.
Publicado: (2015)

Notch signaling pathway: architecture, disease, and therapeutics
por: Zhou, Binghan, et al.
Publicado: (2022)

Emerging roles of Nrf2 signal in non-small cell lung cancer
por: Tian, Yijun, et al.
Publicado: (2016)

CD44 as a tumor biomarker and therapeutic target
por: Xu, Hanxiao, et al.
Publicado: (2020)

Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer
por: Tian, Yijun, et al.
Publicado: (2016)

DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells
por: Chu, Qian, et al.
Publicado: (2014)

DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling
por: Liu, Yu, et al.
Publicado: (2015)

The role of CD44 in epithelial–mesenchymal transition and cancer development
por: Xu, Hanxiao, et al.
Publicado: (2015)

The clinical significance of CXCL5 in non-small cell lung cancer
por: Wu, Kongju, et al.
Publicado: (2017)

SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway
por: Huang, Shanshan, et al.
Publicado: (2022)

Biological Significance of NOTCH Signaling Strength
por: Shen, Wei, et al.
Publicado: (2021)

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
por: Xu, Hanxiao, et al.
Publicado: (2016)

Recent advances of highly selective CDK4/6 inhibitors in breast cancer
por: Xu, Hanxiao, et al.
Publicado: (2017)

The expression profile and clinic significance of the SIX family in non-small cell lung cancer
por: Liu, Qian, et al.
Publicado: (2016)

Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells
por: Zhang, Peng, et al.
Publicado: (2014)

Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling
por: Jue, Chen, et al.
Publicado: (2016)

DACH1 suppresses breast cancer as a negative regulator of CD44
por: Xu, Hanxiao, et al.
Publicado: (2017)

GTPBP4: A New Therapeutic Target Gene Promotes Tumor Progression in Non-Small Cell Lung Cancer via EMT
por: Wu, Junlu, et al.
Publicado: (2022)

Recent advances of bispecific antibodies in solid tumors
por: Yu, Shengnan, et al.
Publicado: (2017)

MiRNA-mediated EMT and CSCs in cancer chemoresistance
por: Dong, Bing, et al.
Publicado: (2021)

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers
por: Tian, Yijun, et al.
Publicado: (2017)

Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine
por: Xu, Hanxiao, et al.
Publicado: (2018)

A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
por: Yuan, Xun, et al.
Publicado: (2016)

Hypoxic Preconditioning Enhances Biological Function of Endothelial Progenitor Cells via Notch-Jagged1 Signaling Pathway
por: Wang, Qian, et al.
Publicado: (2017)

Notch signaling induces EMT in OSCC cell lines in a hypoxic environment
por: ISHIDA, TAKAYUKI, et al.
Publicado: (2013)

Notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian cancer cells
por: Qian, Xue-qian, et al.
Publicado: (2020)

Notch signaling and non-small cell lung cancer
por: Zou, Bin, et al.
Publicado: (2018)

Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma
por: Natsuizaka, Mitsuteru, et al.
Publicado: (2017)

Gut microbiome modulates efficacy of immune checkpoint inhibitors
por: Yi, Ming, et al.
Publicado: (2018)

Endogenous Dach1 in cancer
por: Wu, Kongming, et al.
Publicado: (2015)

TFAP2A Induced KRT16 as an Oncogene in Lung Adenocarcinoma via EMT
por: Yuanhua, Liu, et al.
Publicado: (2019)

Focal adhesion kinase: from biological functions to therapeutic strategies
por: Tan, Ximin, et al.
Publicado: (2023)

Tumor organoids: applications in cancer modeling and potentials in precision medicine
por: Xu, Hanxiao, et al.
Publicado: (2022)

Notch signaling in lung diseases: focus on Notch1 and Notch3
por: Zong, Dandan, et al.
Publicado: (2016)

FOXP3 facilitates the invasion and metastasis of non-small cell lung cancer cells through regulating VEGF, EMT and the Notch1/Hes1 pathway
por: Li, Chun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m6c8ld5l2ahf639nmn6q1mm0uj